Technical Analysis for GRTS - Gritstone Oncology, Inc.

Grade Last Price % Change Price Change
grade A 20.61 -7.08% -1.57
GRTS closed down 7.08 percent on Monday, December 17, 2018, on 1.13 times normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical GRTS trend table...

Date Alert Name Type % Chg
Dec 17 New Downtrend Bearish 0.00%
Dec 17 50 DMA Support Bullish 0.00%
Dec 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Dec 17 Multiple of Ten Bullish Other 0.00%
Dec 17 Strong but Oversold Other 0.00%
Dec 17 Wide Bands Range Expansion 0.00%
Dec 17 Down 3 Days in a Row Weakness 0.00%
Dec 17 Down 4 Days in a Row Weakness 0.00%
Dec 17 Down 5 Days in a Row Weakness 0.00%
Dec 17 Oversold Stochastic Weakness 0.00%

Older signals for GRTS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to drive the patient’s immune system to attack and destroy tumors.
Is GRTS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.9
52 Week Low 11.22
Average Volume 156,317
200-Day Moving Average 0.0
50-Day Moving Average 20.1394
20-Day Moving Average 25.038
10-Day Moving Average 26.271
Average True Range 2.5824
ADX 38.24
+DI 22.8398
-DI 24.9052
Chandelier Exit (Long, 3 ATRs ) 25.1528
Chandelier Exit (Short, 3 ATRs ) 27.2072
Upper Bollinger Band 30.9043
Lower Bollinger Band 19.1717
Percent B (%b) 0.12
BandWidth 46.859174
MACD Line 0.9571
MACD Signal Line 1.9742
MACD Histogram -1.0171
Fundamentals Value
Market Cap 262.88 Thousand
Num Shares 12.8 Thousand
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.58
Resistance 3 (R3) 27.01 25.46 25.59
Resistance 2 (R2) 25.46 23.94 25.24 25.25
Resistance 1 (R1) 23.03 23.00 22.26 22.60 24.92
Pivot Point 21.48 21.48 21.09 21.26 21.48
Support 1 (S1) 19.05 19.96 18.28 18.62 16.30
Support 2 (S2) 17.50 19.02 17.28 15.97
Support 3 (S3) 15.07 17.50 15.64
Support 4 (S4) 14.64